4//SEC Filing
O'Dowd Sarah A 4
Accession 0001209191-21-036664
CIK 0001377121other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:50 PM ET
Size
5.8 KB
Accession
0001209191-21-036664
Insider Transaction Report
Form 4
O'Dowd Sarah A
Director
Transactions
- Award
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 totalExercise: $35.23Exp: 2031-05-26→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest at the earlier of (i) May 27, 2022, or (ii) the date of the 2022 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan).
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001447149
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 6:50 PM ET
- Size
- 5.8 KB